Granulomatosis with polyangiitis a challenge for diagnosis and treatment - case report

Anca Codreanu, Madalina Ionela Chiriac, Elena Rezus

Abstract


In this article we report the case of a 46 year-old male presenting with pulmonary, sinusal, otic, nasal and laryngeal lesions. He was diagnosed in December 2013 with granulomatosis with polyangiitis and we tried to achieve remission with cyclophosphamide and glucocorticoids. The onset of the disease included pansinusitis accompanied with mastoiditis and paralysis of the left facial nerve, bilateral hearing loss and episodes of intense headache. The patient underwent two surgeries to solve the Ear-Nose-Throat (ENT) area symptoms which have delayed the diagnosis and the initiation of appropriate therapy.

Keywords


granulomatosis with polyangiitis, ENT, necrotizing glomerulonephritis, “saddle” nose

Full Text:

PDF

References


Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings. Arch Path Lab Med 2014; 138(8):1110-1114.

Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488–498.

Maronian NC, Azadeh H, Waugh P, Hillel A. Association of laryngopharyngeal reflux disease and subglottic stenosis. Ann Otol Rhinol Laryngol 2001; 110:606–612.

Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9:283–289.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A,Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004; 19:1403–1411.

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ and the Glomerular Disease Collaborative Network. Prognostic markers in patients with antineutrophil cytoplasmic autoantibodyassociated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:23–32.

Booth AD, Almond MK, Burns A, et al. Outcome of ANCA associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41:776–784.

Franssen CFM, Gans ROB, Arends B, et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47:193–199.

de Groot K, Harper L, Jayne DRW, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody–associated vasculitis: a randomized trial. Ann Intern Med 2009; 150:670–680.

Harper L, Morgan MD, Walsh M, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis 2012; 71:955–960.




DOI: http://dx.doi.org/10.22551/2014.02.0102.10013

Copyright (c)

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

ISSN: 2360-6975